The Future of Venture Capital: Humans vs. Machines
As venture capital firms look to gain a competitive advantage in an increasingly crowded space, GV has turned to a computer algorithm, named "The Machine", to guide investment decision making.
As venture capital firms look to gain a competitive advantage in an increasingly crowded space, GV has turned to a computer algorithm, named "The Machine", to guide investment decision making.
There is a large shortage of organs available for lifesaving transplants. As a result medical researchers are turning to 3D bioprinting to address the growing shortage. Swedish start-up Cellink is revolutionizing the bioprinting industry with its innovative bioink, making bioprinting more widely accessible.
This post discusses how BlackRock is leveraging AI more broadly and ML specifically for process improvement and product development, which could result in potentially significant revenue generation.
The U.S. government has turned to crowdsourcing to help solve some of the most pressing public health issues.
Boeing has leveraged additive manufacturing to improve upon its existing production processes. To what extent can Boeing continue to capitalize off of these capabilities and what obstacles stand in its way?
Exploring machine learning developments in the oil and gas industry
Volkswagen is leading the pack in integrating additive manufacturing into its production process. But is this technology scalable? Can it ever materially impact VW's bottom line?
Open innovation, in which companies and organization source information from external sources, helps businesses approach strategic decisions in a creative manner. UNHCR, whose goals are to implement changes external to its organization, would highly benefit from sourcing information and potential solutions from the very people they are trying to help.
The public can help fill gaps in government capacity and drive newfound productivity – but only if the city has the means to turn data into action.
Memorial Sloan-Kettering Cancer Center: On the Cutting-Edge of Cancer Care